A/Prof Steven David
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
49 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial
DOI: 10.1038/s41467-026-75660-y2026
Journal article
Does stereotactic ablative body radiotherapy (SABR) added to continued systemic therapy improve time to treatment failure compared with physician's choice of systemic therapy in oligoprogressive ER-positive, HER2-negative advanced breast cancer? Study protocol for a multicentre, randomised, open-label phase II trial in Australian tertiary cancer centres (AVATAR-II)
DOI: 10.1136/bmjopen-2026-1198112026
Journal article
Intraoperative radiation therapy delivered at the time of lumpectomy for treatment of early-stage breast cancer: Median five-year follow-up outcomes of the single-arm, prospective, multi-institution ExBRT trial
DOI: 10.1016/j.soi.2026.1002712026
Journal article
Real-World Endpoints in Stereotactic Body Radiation Therapy Trials for Oligoprogression: Beyond Progression-Free Survival and Overall Survival
DOI: 10.1016/j.ijrobp.2025.08.0092026
Journal article
Case Report: Serial stereotactic radiotherapy in lieu of systemic therapy change for oligoprogressive breast cancer: eight courses to 17 metastases
DOI: 10.3389/fonc.2026.16418762026
Journal article
Acute Toxicity With Trastuzumab Emtansine and Concurrent Radiotherapy: Non-Consecutive Case Series
DOI: 10.1111/ajco.701462025
Journal article
Baseline tumour burden and prognosis in breast cancer treated with immune checkpoint inhibitors
DOI: 10.1016/j.breast.2025.104586
RECENT SCHOLARLY WORKS
2025
Journal article
Stereotactic Ablative Body Radiotherapy for Oligoprogressive Estrogen Receptor–Positive Breast Cancer (TROG 20.03 AVATAR): A Phase II Prospective Multicenter Trial
DOI: 10.1200/oa-25-000312025
Conference Proceedings
Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study
DOI: 10.1016/j.breast.2024.1038612024
Journal article
Sustained lymphocyte decreases after treatment for early breast cancer
DOI: 10.1038/s41523-024-00698-4